Cumberland Pharmaceuticals (CPIX) Tops Q2 EPS by 3c, Revenues Miss
Tweet Send to a Friend
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.10, $0.03 better than the analyst estimate of $0.07. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
